Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:56 PM
Ignite Modification Date:
2025-12-24 @ 11:56 PM
NCT ID:
NCT04139551
Eligibility Criteria:
Inclusion Criteria:
* The participant may enter the study as a patient participant if ALL of the following apply:
* Participant is willing and able to give informed consent for participation in the study
* Fluent in English
* Male or Female, aged 50 years or above
* Patient diagnosed with PD or PSP by a specialist movement disorders neurologist, or age matched healthy control (often but not always the spouse of a patient)
* No evidence of significant cognitive impairment
* Normal or corrected-to-normal vision in both eyes
The participant may enter the study as a healthy control if ALL of the following apply:
* Participant is willing and able to give informed consent for participation in the study
* Fluent in English
* Male or Female, aged 50 years or above
* No history of neurological disease
* No evidence of significant cognitive impairment
* Normal or corrected-to-normal vision in both eyes
Exclusion Criteria:
The participant may not enter the study if ANY of the following apply:
* Patient is unwilling or unable to give informed consent.
* Significant neurological co-morbidity that may obfuscate interpretation of neurophysiological or cognitive test results, for example major stroke.
* Severe mental impairment due to dementia or psychosis
* Medical or psychiatric illness that would interfere with completing initial or any of the follow up assessments
* History of photosensitive epilepsy
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
50 Years
Study:
NCT04139551
Study Brief:
Protocol Section:
NCT04139551